AS
Altshuler Shaham Portfolio holdings
AUM
$3.14B
1-Year Return
24.55%
This Quarter Return
+1.49%
1 Year Return
+24.55%
3 Year Return
+51.84%
5 Year Return
+71.45%
10 Year Return
–
AUM
$4.73B
AUM Growth
-$8.91B
(-65%)
Cap. Flow
-$9.2B
Cap. Flow
% of AUM
-194.35%
Top 10 Holdings %
Top 10 Hldgs %
81.15%
Holding
643
New
148
Increased
104
Reduced
139
Closed
157
Top Buys
Top Sells
| 1 |
Apple
AAPL
|
+$1.04B |
| 2 |
Amazon
AMZN
|
+$842M |
| 3 |
Palo Alto Networks
PANW
|
+$721M |
| 4 |
Blackrock
BLK
|
+$615M |
| 5 |
Fortinet
FTNT
|
+$615M |
Sector Composition
| 1 | Technology | 37.78% |
| 2 | Financials | 27.68% |
| 3 | Consumer Discretionary | 2.49% |
| 4 | Consumer Staples | 2.2% |
| 5 | Healthcare | 0.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Annaly Capital Management
NLY
$14.2B
| $59K | ﹤0.01% |
1,857
-1,571
| -46% | -$49.9K |
|
|
EPAY
352
DELISTED
Bottomline Technologies Inc
EPAY
| $54K | ﹤0.01% |
+961
| New | +$54K |
|
|
VCRA
353
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $54K | ﹤0.01% |
+829
| New | +$54K |
|
354
Amphastar Pharmaceuticals
AMPH
$1.36B
| $53K | ﹤0.01% |
+2,267
| New | +$53K |
|
355
McKesson
MCK
$86.7B
| $53K | ﹤0.01% |
+213
| New | +$53K |
|
356
AMN Healthcare
AMN
$806M
| $52K | ﹤0.01% |
426
-4
| -0.9% | -$488 |
|
357
Dover
DOV
$24.4B
| $52K | ﹤0.01% |
287
-1,085
| -79% | -$197K |
|
358
Merck
MRK
$210B
| $52K | ﹤0.01% |
661
-1,870
| -74% | -$147K |
|
359
Option Care Health
OPCH
$4.8B
| $52K | ﹤0.01% |
+1,835
| New | +$52K |
|
360
Premier
PINC
$2.24B
| $52K | ﹤0.01% |
+1,268
| New | +$52K |
|
361
Revvity
RVTY
$10B
| $52K | ﹤0.01% |
258
-422
| -62% | -$85.1K |
|
362
Bio-Techne
TECH
$8.42B
| $52K | ﹤0.01% |
404
-52
| -11% | -$6.69K |
|
363
Travere Therapeutics
TVTX
$1.89B
| $52K | ﹤0.01% |
+1,663
| New | +$52K |
|
364
Abbott
ABT
$230B
| $51K | ﹤0.01% |
361
-28
| -7% | -$3.96K |
|
365
Avantor
AVTR
$8.95B
| $51K | ﹤0.01% |
1,210
-23
| -2% | -$969 |
|
366
Chemed
CHE
$6.76B
| $51K | ﹤0.01% |
97
-8
| -8% | -$4.21K |
|
367
CorVel
CRVL
$4.64B
| $51K | ﹤0.01% |
729
-162
| -18% | -$11.3K |
|
368
Harmony Biosciences
HRMY
$2.06B
| $51K | ﹤0.01% |
+1,202
| New | +$51K |
|
369
Labcorp
LH
$23B
| $51K | ﹤0.01% |
187
-605
| -76% | -$165K |
|
370
Riot Platforms
RIOT
$4.97B
| $51K | ﹤0.01% |
2,000
| – | – |
|
|
EGRX
371
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $51K | ﹤0.01% |
+1,004
| New | +$51K |
|
372
Alkermes
ALKS
$4.7B
| $50K | ﹤0.01% |
2,131
-1,938
| -48% | -$45.5K |
|
373
AngioDynamics
ANGO
$443M
| $50K | ﹤0.01% |
1,805
+38
| +2% | +$1.05K |
|
374
Bruker
BRKR
$4.67B
| $50K | ﹤0.01% |
591
-739
| -56% | -$62.5K |
|
375
Danaher
DHR
$142B
| $50K | ﹤0.01% |
173
-24
| -12% | -$6.94K |
|